Brilique 90 mg orodispersible tablets

Company
AstraZeneca Pharmaceuticals (Ireland) DAC
Active Ingredient
Dosage Form
Orodispersible tablet
Legal Category
B - prescription, may be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/10/655/012 90 milligram(s) B01AC24 Orodispersible tablet
EU/1/10/655/013 90 milligram(s) B01AC24 Orodispersible tablet
EU/1/10/655/014 90 milligram(s) B01AC24 Orodispersible tablet
Licence number
EU/1/10/655/012
Strength
90 milligram(s)
ATC Code
B01AC24
Dosage Form
Orodispersible tablet
Licence number
EU/1/10/655/013
Strength
90 milligram(s)
ATC Code
B01AC24
Dosage Form
Orodispersible tablet
Licence number
EU/1/10/655/014
Strength
90 milligram(s)
ATC Code
B01AC24
Dosage Form
Orodispersible tablet

AstraZeneca Pharmaceuticals (Ireland) DAC

College Business and Technology Park, Blanchardstown Road North, Dublin 15, D15 R925, D15 R925 Dublin

Website
https://contactazmedical.astrazeneca.com
Telephone
+35316097100
Email
mipqc.ireland@astrazeneca.com